Last €84.60 EUR
Change Today -0.30 / -0.35%
Volume 2.6M
SAN On Other Exchanges
Symbol
Exchange
EN Paris
EN Paris
New York
OTC US
BrsaItaliana
Mexico
Frankfurt
Frankfurt
NASDAQ GM
As of 11:36 AM 10/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jérôme Contamine

Chief Financial Officer and Executive Vice President, Sanofi
AgeTotal Calculated CompensationThis person is connected to 12 board members in 1 different organizations across 8 different industries.

See Board Relationships
56--

Background*

Mr. Jérôme Contamine, also known as Jrme, has been the Chief Financial Officer and Executive Vice President at Sanofi-Aventis since March 16, 2009. Mr. Contamine served as Senior Executive Vice President of Finance of Veolia Environnement S.A. from April 30, 2003 to January 2009 and served as its Chief Financial Officer from June 2000 to January 2009. He served as Deputy General Manager of Veolia Environment. He served as Deputy Managing Director of Veolia Environnement ...

Read Full Background

Corporate Headquarters*

54, Rue La Boétie
Paris, Ile-de-France 75008

France

Phone: 33 1 53 77 40 00
Fax: --

Board Members Memberships*

Former Director and Member of Executive Committee
2000-N/A
Former Director
2004-2009
Former Independent Director and Member of Audit Committee
2006-Present
Independent Director and Chairman of Strategy Committee

Education*

Bachelor's Degree
Ecole Polytechnique France
Bachelor's Degree
Ecole Nationale De La Statistique Et De L'administration Economique Paris
Bachelor's Degree
Ecole Nationale D'Administration
Bachelor's Degree
Institut D'etudes Politiques And Ecole Nationale D'administration

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SAN:FP €84.60 EUR -0.30

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€2.9M
Lars Rebien Sørensen Chief Executive Officer and Member of Executive Management
Novo Nordisk A/S
kr15.2M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SANOFI, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.